Ambulatory blood pressure monitoring and active renin in menopausal women treated with amlodipine and hormone replacement therapy

References

• Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998;12:587–92
   PubMed Web of Science ®Google Scholar
• Szekacs B, Vajo Z, Acs N, et al. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with hypertension. Menopause 2000;7:31–5
   PubMed Web of Science ®Google Scholar
• Harrison-Bernard LM, Raij L. Postmenopausal hypertension. Curr Hypertens Rep 2000;2:202–7
   PubMedGoogle Scholar
• Van Baal WM, Kooistra T, Stehouwer CDA. Cardiovascular disease risk and hormone replace-ment therapy (HRT): a review based on randomised, controlled studies in postmenopausal women. Curr Med Chem 2000;7:499–517
   Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal wo-men. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605–13
   Web of Science ®Google Scholar
• Women's Health Initiative. Risks and benefits of estrogen and progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288: 321–33
   Google Scholar
• Kloner RA, Sowers JR, DiBona GF, et al. Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol 1996;77:713–22
   PubMed Web of Science ®Google Scholar
• Agabiti-Rosei E, Ambrosioni E, Pirelli A, et al.; the MADAM study group. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. Eur J Clin Pharmacol 1999;55:185–9
   Google Scholar
• Tulenko TN, Sumner AE, Chen M, et al. The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotec-tion. Am Heart J 2001; 141 (Suppl 2) :S1–11
   PubMedGoogle Scholar
• Kloner RA, Weinberger M, Pool JL, et al. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hyperten-sion. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol 2001;87:727–31
   Google Scholar
• Staessen JA, Gino cchio G, Thjs L, et al. Conven-tional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997;11:507–14
   PubMed Web of Science ®Google Scholar
• Langdon C. Treatment of hypertension in patients > or = 65 years of age: experience with amlodipine. Gun Ther 2000;22:1473–82
   Google Scholar
• Terpstra WF, May JF, Smit AJ, et al. Long-term effects of amlodipine and lisinopril on left ventri-cular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial. J Hypertens 2001;19:303–9
   PubMed Web of Science ®Google Scholar
• Germano G, Ramponi C, Caparra A, et al. Comparative study of the effects of amlodipine and nitrendipine on 24-hour blood pressure profile. Clin Drug Invest 1997;13(Suppl 1):77–82
   Google Scholar
• Punzi HA, Noveck R, Weiss RJ, et al. Are there differences in the effects of long-acting calcium antagonists on ambulatory blood pressure? Ex-tended-release nisoldipine versus amlodipine as a model. Blood Press Monit 1998;3:267–72
   PubMedGoogle Scholar
• Hernandez R, Armas-Hernandez MJ, Chourio JA, et al. Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses. Blood Press Monit 2001;6:47–57
   PubMed Web of Science ®Google Scholar
• Mercuro G, Zoncu S, Piano D, et al. Estradio1-17 beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998;1:909–13
   Google Scholar
• Hassager C, Christiansen C. Blood pressure during oestrogen/progestogen substitution therapy in healthy post-menopausal women. Maturitas 1988;9: 315–23
   PubMed Web of Science ®Google Scholar
• Pedersen OL, Mikkelsen E, Christensen NJ, et al. Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension. Eur J Clin Pharmacol 1979;15:235–40
   PubMed Web of Science ®Google Scholar
• Koev D, Zacharieva S, Tcharaktchiev D, et al. Effect of nifedipine on renin—angiotensin—aldosterone system and renal prostaglandins in diabetic patients. Diabetes Res 1989;12:63–5
   PubMedGoogle Scholar
• Fray JC, Lush DJ, Valentine AMD. Cellular mechanisms of renin secretion. Fed Proc 1983;42:3150–4
   PubMedGoogle Scholar
• Kazuyuki S, Shirotani M, Yoshida H, et al. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension 1999;33: 1447–52
   PubMedGoogle Scholar
• Schricker K, Hamann M, Macher A, et al. Effect of amlodipine on renin secretion and renin gene expression in rats. Br J Pharmacol 1996;119:744–50
   PubMedGoogle Scholar
• Kokot M, Witkowicz-Kulhawik J, Kokot F. Effect of 12-week treatment with amlodipine on plasma renin activity and adrenal cortex function in patients with essential hypertension. Pol Arch Med Wewn 1997;98:93–9
   PubMedGoogle Scholar
• Wagner C, Kramer BK, Hinder M, etal. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats. Br J Pharmacol 1998;124:579–85
   PubMed Web of Science ®Google Scholar
• Oelkers WK. Effects of estrogens and progestogens on the renin—aldosterone system and blood pressure. Steroids 1996;61:166–71
   PubMed Web of Science ®Google Scholar
• Schunkert H, Jan Danser AH, Hense HW, et al. Effects of estrogen replacement therapy on the renin—angiotensin system in postmenopausal wo-men. Circulation 1997;95:39–45
   PubMed Web of Science ®Google Scholar
• Umeda M, Ichikawa S, Kanda T, et al. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women. Am J Hypertens 2001;14:206–11
   PubMed Web of Science ®Google Scholar
• Seely EW, Walsh BW, Gerhard MD, et al. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 1999;33:1190–4
   PubMed Web of Science ®Google Scholar
• Derkx FHM, deBruin RJA, Gool JMGV, et al. Clinical validation of monoclonal renin antibody sandwich assays of renin and prorenin. Clin Chem 1996;42:1051–63
   PubMed Web of Science ®Google Scholar
• Seed M. Sex hormones, lipoproteins, and cardio-vascular risk. Atherosclerosis 1991;90:1–7
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effect of estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Assoc 1995;273:199–208
   PubMed Web of Science ®Google Scholar
• Paganini-Hill A, Dworsky R, Krauss RIVI. Hor-mone replacement therapy, hormone levels, and lipoprotein cholesterol concentration in elderly women. Obstet Gynecol 1996;174:897–902
   Google Scholar
• Farish E, Spowart K, Barnes JF, et al. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions. Atherosclerosis 1996;126:77–84
   PubMed Web of Science ®Google Scholar
• Ahaneku JE, Sakata K, Urano T, et al. Influence on baseline values of lipids, lipoproteins and fibrinolytic parameters during amlodipine treatment of hyper-tension in Japanese patients. Pharmacol Res 2000;41: 73–7.
   PubMedGoogle Scholar